⸺ Celvora
Tirzepatide
Dual GLP-1 and GIP receptor agonist studied in preclinical models for glucose regulation, insulin sensitivity and energy balance.
Secure checkout. Free shipping on orders over £100.
Independently tested
COA on request
Fast dispatch
Order before 2pm
Research use only
Not for human consumption
⸺ Overview
About Tirzepatide
Tirzepatide simultaneously engages two incretin receptors — GLP-1 and GIP. It is widely used in preclinical research investigating combined incretin signalling.
⸺ Mechanism of Action
How it works
By binding both GLP-1 and GIP receptors, Tirzepatide amplifies the natural incretin response.
⸺ Research
Areas of study
Insulin sensitivity in rodents
Studies in obese rodents show improved insulin sensitivity and glucose tolerance.
Appetite and energy balance
Animal research indicates reduced food intake and altered energy expenditure.
Lipid metabolism
Preclinical work has reported changes in circulating lipid markers.
⸺ Details
Specification
- CAS
- 2023788-19-2
- Intended use
- For research purposes only.
- Storage
- Lyophilised: cool, dry, dark. Reconstituted: refrigerate at 2–8°C.
- Solubility
- Vial holds up to 3mL.
- Shelf life
- Lyophilised: 24 months. Reconstituted: 4–6 weeks refrigerated.
- Handling
- Use sterile technique throughout.
You might also research
View all →
Retatrutide
Investigational triple receptor agonist targeting GLP-1, GIP and glucagon — studied for appetite control, energy expenditure and glucose balance.
Semaglutide
Synthetic analogue of the GLP-1 hormone used in research to study glucose regulation, insulin secretion and the incretin response.
Cagrilintide
Long-acting amylin analogue researched for appetite regulation and weight management, often paired with GLP-1 agonists.